You are here

Urology

Results of the European multi-center study of Bladder EpiCheck™ urine test, supporting reduction of invasive procedures, were published in the European Urology Oncology journal

Multiple SelectMDx Clinical Study Abstracts presented at 2018 Global Prostate Congress in Frankfurt, Germany

MDxHealth SA, today announced the publication of positive data demonstrating the value of the SelectMDx liquid biopsy test for Prostate Cancer in guiding patient management for men being considered for multiparametric MRI and the clinical utility in guiding biopsy decisions in real-world clinical practice. Data will be presented at the sixth Global Congress on Prostate Cancer (PROSCA) in Frankfurt, Germany, June 28-30, 2018.

Image-targeted biopsy of the prostate leads to a substantial increase in the proportion of prostate cores identified as high risk compared with standard transrectal ultrasound (TRUS)-guided biopsy, the results of a UK study indicate.

"This could lead to inflation in risk attribution as a consequence of deliberate oversampling of one part of the prostate - in other words, targeting," say Nicola Robertson (Royal Free Hospital, London) and colleagues. "New risk stratification models may be required for men who have pathology derived from image-directed biopsy strategies."

A new approach to analyzing prostate gland tissue may help address a major challenge in treating prostate cancer - determining which tumors are unlikely to progress and which could be life threatening and require treatment. In their report published in the journal Scientific Reports, Massachusetts General Hospital (MGH) investigators describe how cellular metabolites - proteins produced as the results metabolic processes - in apparently benign tissues from cancerous prostates not only can determine the grade and stage of the tumor but also can predict its risk of recurrence.

Physicians now have a more dependable, less expensive tool to help detect bladder cancer earlier.

Researchers at The University of Texas M. D. Anderson Cancer Center found that a simple test that can be administered and read in the doctor's office was three times more effective than a conventional laboratory test for detecting bladder cancer.

Considered a safe and highly effective contraception method, intrauterine devices (IUDs) may also be quietly offering protection against the third-most common cancer in women worldwide. A new study from the Keck School of Medicine of USC has found that IUD use is associated with a dramatic decrease in the incidence of cervical cancer.

Subscribe to Urology